Nuclear transport modulators and uses thereof
US10526295B2 · kind B2 · utility
11Cited by
29References
20Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Dec 30, 2016 |
| Grant date | Jan 7, 2020 |
| Priority date | — |
| Expiry date | Dec 30, 2036 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D413/12
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention relates to compounds of formula (I): and pharmaceutically acceptable salts thereof, pharmaceutical compositions comprising the compounds of formula I or their pharmaceutically acceptable salts, and methods of using said compounds, salts and compositions in the treatment of various disorders associated with CRM1 activity.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.